Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NT(8-13)

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Crystal structures of neurotensin receptor subtype 1 (NTS1) allowed us to visualize the binding mode of the endogenous peptide… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
2011
2011
New macrocyclic 1,4,8,11-tetraazacyclotetradecane (cyclam) derivatives with 1, 2 and 4 neurotensin(8-13) units 4, 5 and 7 have… Expand
Highly Cited
2007
Highly Cited
2007
Receptors for endogenous regulatory peptides, like the neuropeptide neurotensin, are overexpressed in several human cancers and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2006
2006
OBJECTIVES To prepare 99m technetium (99mTc)-labeled neurotensin (NT) peptide and to evaluate the feasibility of imaging oncogene… Expand
Highly Cited
2002
Highly Cited
2002
UNLABELLED The rapid degradation of neurotensin (NT) limits its clinical use in cancer imaging and therapy. Thus, a new NT(8--13… Expand
Highly Cited
2000
Highly Cited
2000
The tridecapeptide neurotensin has long been proposed as an endogenous neuroleptic. However, for neurotensin [or neurotensin(8-13… Expand
1984
1984
1 The antinociceptive effects of synthetic neurotensin (NT), its fragments and analogues administered into the lateral… Expand